 Helius has now expanded access for patients seeking PoNS Treatment to fourteen clinics in Canada, with eight in Ontario, the most populous province. Our progress in authorizing seven new clinics during the first two months of 2020 reflects the success of our new commercial strategy to enhance clinic engagement and increase the adoption of our PoNS Treatment, said Philippe Deschamps, Chief Executive Officer of Helius. 